GlassScriptPhysician profile
Nicholas William Todd
NPI 1851695712
$194,413.15
in general payments reported to CMS, 2019-2025
15 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $27K · 2021: $46K · 2022: $29K · 2023: $24K · 2024: $15K · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $4,808 · Consulting Fee: $1,950 · Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,591.00 |
| Travel and Lodging | $4,808.02 |
| Consulting Fee | $1,950.00 |
| Food and Beverage | $1,772.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $128,220.41 | 2019-2025 | Distal Extremities Implants Foot & Ankle Metal Compression Screws, Arthrex, Distal Extremities Implants Foot & Ankle Ankle Arthroplasty |
| Organogenesis INC. | $61,774.03 | 2019-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Evolution Surgical, INC | $3,099.31 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $437.50 | 2019 | |
| Osiris Therapeutics INC. | $192.65 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $167.86 | 2020 | |
| Integra Lifesciences Corporation | $137.34 | 2019 | |
| Nevro Corp. | $103.75 | 2021 | |
| Paragon 28, INC. | $99.74 | 2019 | |
| Depuy Synthes Sales INC. | $56.81 | 2024 | Trumatch |
| Sanara Medtech INC. | $38.60 | 2024 | Biasurge |
| Stryker Corporation | $25.15 | 2025 | Prostep |
| Smith+Nephew, INC. | $24.51 | 2019 | |
| Solventum Corporation | $20.42 | 2024 | Activ.A.C. |
| In2bones USA, LLC | $15.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.